5 completed. 3 Phase 3, 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Completed 3 |
| Phase 1 | 2 | Completed 2 |
Follow GW406381X: new trials by email Literature Review of GW406381X trials Research Report on GW406381X
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study Of GW406381 In Volunteers With Moderate Hepatic Impairment GW406381 - Pain | Phase 1 | Completed | GlaxoSmithKline | 24 | 2005-10-19 | 2017-09-11 |
| COX-2 Inhibitor Study In Patients With Rheumatoid Arthritis GW406381 - Arthritis, Rheumatoid | Phase 3 | Completed | GlaxoSmithKline | 2208 | 2005-06-01 | 2017-03-14 |
| Evaluation of GW406381 in Treating Adults With Osteoarthritis Of The Knee GW406381 - Osteoarthritis, Knee | Phase 3 | Completed | GlaxoSmithKline | 1340 | 2005-05-01 | 2017-01-19 |
| Dental Pain (Following Third Molar Tooth Extraction) Study GW406381 - Dental Pain, Surgery, Dental | Phase 3 | Completed | GlaxoSmithKline | 300 | 2004-12-01 | 2017-01-19 |
| GW406381 In Patients With Peripheral Nerve Injury GW406381 - Hyperalgesia, Neurodynia | Phase 1 | Completed | GlaxoSmithKline | 40 | 2003-09-01 | 2009-02-23 |
Pain (2) · Arthritis, Rheumatoid (1) · Hyperalgesia (1) · Neuralgia (1) · Osteoarthritis, Knee (1) · Peripheral Nerve Injuries (1) · Toothache (1) · Wounds and Injuries (1)
GlaxoSmithKline (5)
Denmark (2) · Hungary (2) · Netherlands (2) · Norway (2) · South Korea (2) · Spain (2) · United Kingdom (2) · United States (2) · Argentina (1) · Austria (1) · Belgium (1) · Bulgaria (1) · Canada (1) · Chile (1) · Costa Rica (1)